• 제목/요약/키워드: dose of prescription

검색결과 315건 처리시간 0.025초

소아의 한약복용에 관한 임상적 실태 조사 (Clinical investigation of child dose of herb medicine)

  • 서정민;이상곤;황순이;김상찬;왕향란;조성언;백정한
    • 대한한방소아과학회지
    • /
    • 제20권3호
    • /
    • pp.33-50
    • /
    • 2006
  • Objectives : Oriental medicine has set the no herb medicamentous dose for child, on the other hand the western medicine has it standardizing of age, weight or dimension of body. Therefore, we aimed to research the herb medicamentous dose for child being in being used in clinic. Methods : We made up a question of the oriental medical doctors of the master's and doctor's course in ○○ university. Results : 1. Child dose of herb medicine a time likes this. 1 pack is written prescription most at children patients under 1 year. 1 pack and 2 packs are written prescription most at children patients over 1 under 2. 2 packs are written prescription most at children patients over 2 under 3. 4 packs are written prescription most at children patients over 3 under 4. 10 packs are written prescription most at children patients over 8 under 14. Dose of herb medicine written prescription at children patients over 5 under 8 is in decentralization from 2 to 10 packs. 2. 2 or 3 times are most in a number of taking medicine a day. 3. 3 days are common in period of taking medicine under 5, over 10 days are common over 5. 4. It is necessary to regulating child dose of herb medicine.

  • PDF

Determining the Optimal Dose Prescription for the Planning Target Volume with Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer Patients

  • Liu, Xi-Jun;Lin, Xiu-Tong;Yin, Yong;Chen, Jin-Hu;Xing, Li-Gang;Yu, Jin-Ming
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권5호
    • /
    • pp.2573-2577
    • /
    • 2016
  • Objective: The aim of this study was to determine a method of dose prescription that minimizes normal tissue irradiation outside the planning target volume (PTV) during stereotactic body radiotherapy (SBRT) for patients with non-small cell lung cancer. Methods: Previous research and patients with typical T1 lung tumors with peripheral lesions in the lung were selected for analysis. A PTV and several organs at risk (OARs) were constructed for the dose calculated; six treatment plans employing intensity modulated radiotherapy (IMRT) were produced, in which the dose was prescribed to encompass the PTV, with the prescription isodose level (PIL) set at 50, 60, 70, 80, 90 or 95% of the isocenter dose. Additionally, four OARs around the PTV were constructed to evaluate the dose received in adjacent tissues. Results: The use of higher PILs for SBRT resulted in improved sparing of OARs, with the exception of the volume of lung treated with a lower dose. Conclusions: The use of lower PILs is likely to create significant inhomogeneity of the dose delivered to the target, which may be beneficial for the control of tumors with poor conformity indices.

Ir-192 선 선원의 선량분포에 관한 품질보증 (Quality Assurance on Dose Distribution of Ir-192 Line Source)

  • 김종언
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제30권1호
    • /
    • pp.33-38
    • /
    • 2007
  • 이 연구는 플라토 치료계획시스템의 치료계획에서 Ir-192 선원에 대한 처방점의 처방선량과 선원 주위의 선량분포상의 선량점들의 선량이 정확하게 계산되는지를 확인하는데 그 목적이 있다. 선원의 중심축의 전후방향에서의 평면의 직교좌표계와 측면방향에서의 평면의 직교좌표계 및 선원을 A4 용지 위에 그려서 치료계획시스템에 입력하였다. 처방선량은 선원중심으로부터 극각 $90^{\circ}, $270^{\circ}의 방향으로 반경 1 cm인 두 지점에 400 cGy를 처방하였다. 처방점과 선량점들의 선량은 치료계획시스템에서 출력된 선량과 파울 킹 등이 유도한 기하학 함수식으로 계산된 선량을 분석하였다. 본 실험의 분석에서 처방 점의 선량은 오차 없이 정확하게 일치하였고, 선량 점들의 선량은 1.85% 이내의 오차를 얻었다. 그리고 플라토 치료계획시스템의 선량계산은 허용오차 ${\pm}2%$ 범위 이내의 정확성으로 분석되었다. 파울 킹 등이 유도한 기하학 함수식을 사용하여 손으로 계산한 선량은 높은 정확성의 품질보증과 편리성에 기인하여, 임상에서 사용하는데 유용할 것으로 생각된다.

  • PDF

상한잡병론(傷寒雜病論)의 약물제량(藥物劑量)에 관한 고찰 (A Study on the Dose of Prescription in Shanghanlun)

  • 신흥묵
    • 대한한의학회지
    • /
    • 제20권3호
    • /
    • pp.3-8
    • /
    • 1999
  • This study was carried out to investigate the dose of prescription in Shanghanlun. To this end, literature research and a survey of several herbal medicines have been done. As a result, the weight of 1 liang (兩) is determined to be about 15g. Furthermore, we find that Jung-Kyung Jang, who compiled Shang-hanlun, used a great quantity of herbal medicines to treat critical conditions of iIInesses. Therefore application of Shang-hanIun s prescriptions according to the various conditions of patients must have changed the quantity of dosage.

  • PDF

자궁경구암(子宮頸口癌) 강내조사치료시(腔內照射治療時) A점(點) B점(點) 선량계산방법(線量計算方法)과 mghr 단위(單位) 방법(方法)의 비교(比較) (A Comparision of Mghr Prescription to Doses at Ponts A and B in Intracavitary Radiotherapy of Cervix Cancer)

  • 박찬일;하성환;강위생
    • Journal of Radiation Protection and Research
    • /
    • 제6권1호
    • /
    • pp.31-33
    • /
    • 1981
  • The 42 patients with carcinoma of the cervix, performed intracavitary radiotherapy, were analysed the doses at points A and B comparing to the mghr prescription. The doses at points A and B were calculated by PC-12 computer planning system. Correlation coefficienty between doses at points A and B and the mghr prescription are 0.82 (p<0.001) and 0.90 (p<0.001) respectively. The slope of the point A line is 0.70 and the slope of the point B is 0.21. Therefore, the dose at point A is approximately 3/4 the mghr prescription and the dose at point B is approximately 1/4 the mghr precription.

  • PDF

호두인 에탄올 추출물의 사고화탄소 유도 간섬유화 억제 효과 (Inhibitory effects of the Juglans sinensis Walnut Ethanol Extract on Carbon Tetrachloride-induced hepatic fibrosis in Rats)

  • 장선일;임창경;유진덕;김희수;윤용갑
    • 동의생리병리학회지
    • /
    • 제17권5호
    • /
    • pp.1264-1269
    • /
    • 2003
  • The inhibitory effects of the Juglans sinensis walnut ethanol extract (JSWE) on carbon tetrachloide (CCl₄)-induced fibrosis, serum transaminases (GOT and GTP), hepatic glutathione (GSH), serum pro-inflammatory cytokines (IL-1β and IL-6) were investigated in rats. JSWE significantly inhibited on CCl₄-induced fibrosis in dose-dependent manner. Moreover, JSWE significantly inhibited on the serum levels of GOT, GTP, IL-1β, and IL-6 in dose-dependent manner in CCl₄-induced fibrosis rat. However, JSWE markedly increased the production of hepatic GSH in a dose-dependent manner. These results show that JSWE may explain some known biological activities of Juglans sinensis walnut including their anti-fibrotic and anti-inflammatory effects, and is of considerable benefit in the treatment for live diseases.

Cyberknife Dosimetric Planning Using a Dose-Limiting Shell Method for Brain Metastases

  • Yoon, Kyoung Jun;Cho, Byungchul;Kwak, Jung Won;Lee, Doheui;Kwon, Do Hoon;Ahn, Seung Do;Lee, Sang-Wook;Kim, Chang Jin;Roh, Sung Woo;Cho, Young Hyun
    • Journal of Korean Neurosurgical Society
    • /
    • 제61권6호
    • /
    • pp.753-760
    • /
    • 2018
  • Objective : We investigated the effect of optimization in dose-limiting shell method on the dosimetric quality of CyberKnife (CK) plans in treating brain metastases (BMs). Methods : We selected 19 BMs previously treated using CK between 2014 and 2015. The original CK plans ($CK_{original}$) had been produced using 1 to 3 dose-limiting shells : one at the prescription isodose level (PIDL) for dose conformity and the others at low-isodose levels (10-30% of prescription dose) for dose spillage. In each case, a modified CK plan ($CK_{modified}$) was generated using 5 dose-limiting shells : one at the PIDL, another at intermediate isodose level (50% of prescription dose) for steeper dose fall-off, and the others at low-isodose levels, with an optimized shell-dilation size based on our experience. A Gamma Knife (GK) plan was also produced using the original contour set. Thus, three data sets of dosimetric parameters were generated and compared. Results : There were no differences in the conformity indices among the $CK_{original}$, $CK_{modified}$, and GK plans (mean 1.22, 1.18, and 1.24, respectively; p=0.079) and tumor coverage (mean 99.5%, 99.5%, and 99.4%, respectively; p=0.177), whereas the $CK_{modified}$ plans produced significantly smaller normal tissue volumes receiving 50% of prescription dose than those produced by the $CK_{original}$ plans (p<0.001), with no statistical differences in those volumes compared with GK plans (p=0.345). Conclusion : These results indicate that significantly steeper dose fall-off is able to be achieved in the CK system by optimizing the shell function while maintaining high conformity of dose to tumor.

Feasibility Study of Mobius3D for Patient-Specific Quality Assurance in the Volumetric Modulated Arc Therapy

  • Lee, Chang Yeol;Kim, Woo Chul;Kim, Hun Jeong;Lee, Jeongshim;Huh, Hyun Do
    • 한국의학물리학회지:의학물리
    • /
    • 제30권4호
    • /
    • pp.120-127
    • /
    • 2019
  • Purpose: This study was designed to evaluate the dosimetric performance of Mobius3D by comparison with an aSi-based electronic portal imaging device (EPID) and Octavius 4D, which are conventionally used for patient-specific prescription dose verification. Methods: The study was conducted using nine patients who were treated by volumetric modulated arc therapy. To evaluate the feasibility of Mobius3D for prescription dose verification, we compared the QA results of Mobius3D to an aSi-based EPID and the Octavius 4D dose verification methods. The first was the comparison of the Mobius3D verification phantom dose, and the second was to gamma index analysis. Results: The percentage differences between the calculated point dose and measurements from a PTW31010 ion chamber were 1.6%±1.3%, 2.0%±0.8%, and 1.2%±1.2%, using collapsed cone convolution, an analytical anisotropic algorithm, and the AcurosXB algorithm respectively. The average difference was found to be 1.6%±0.3%. Additionally, in the case of using the PTW31014 ion chamber, the corresponding results were 2.0%±1.4%, 2.4%±2.1%, and 1.6%±2.5%, showing an average agreement within 2.0%±0.3%. Considering all the criteria, the Mobius3D result showed that the percentage dose difference from the EPID was within 0.46%±0.34% on average, and the percentage dose difference from Octavius 4D was within 3.14%±2.85% on average. Conclusions: We conclude that Mobius3D can be used interchangeably with phantom-based dosimetry systems, which are commonly used as patient-specific prescription dose verification tools, especially under the conditions of 3%/3 mm and 95% pass rate.

동의보감(東醫寶鑑) 중 석고(石膏)가 주약(主藥)으로 배오(配伍)된 방제(方劑)의 활용(活用)에 대한 고찰(考察) (A Study on Application of Gypsum Main Blended Prescription From Dongeuibogam)

  • 오황;이장천
    • 대한한의학방제학회지
    • /
    • 제15권1호
    • /
    • pp.1-19
    • /
    • 2007
  • This study was investigated to make sure the range of Gypsum treatment, the nature of disease, the pathology and the dosage of it in Dongeuybogam. The following conclusions were reached through investigations on the prescriptions that use Gypsum as a key ingredient. The Gypsum blended prescriptions are utilized in 23 fields of treatment such as cold, head. ect. Prescriptions that use Gypsum as the main ingredient are used commonly in the treatment of cold, head disease, fever, skin disease, diabetes, stroke, ophthalmic disease, jaundice, ENT disease and dental disease. The Gypsum is used for nature of disease which of cold, heat(fever), summer heat, phlegm, malfunction of liver, malfunction of liver and kidney, heat of stomach, malfunction of spleen and fever of stomach. The clinical dosage of Gypsum has ranged at a wide variety of amount from 1.6g to 16g per dose with 4g ${\sim}$ 8g being the typical dose for most treatment. The Gypsum is applied as a fundamental prescription with several herb remedies for the pathology.

  • PDF

좌측 유방에 대한 용적 변조 회전 방사선 치료 시 자세 오차로 인한 피부 선량 (Comparison of dose-variation in skin due to Set-up error in case of radiation therapy for left breast using Volumetric Modulated Arc Therapy(VMAT))

  • 권용재;박령황;김세영;정동민;백종걸;조정희
    • 대한방사선치료학회지
    • /
    • 제33권
    • /
    • pp.55-62
    • /
    • 2021
  • 목 적: 방사선 피부염은 유방암 방사선 치료로 인해 발생하는 가장 흔한 부작용 중 하나로 본 연구는 자세오차에 따른 피부선량 차이를 분석하여 방사선 치료 부작용을 줄이고자 한다. 대상 및 방법 : 3D 프린터를 이용하여 유방 모형을 제작하고, 그것을 팬텀에 적용하였으며, 컴퓨터단층촬영을 통해 영상을 획득하였다. 처방선량의 95%가 들어가는 치료계획용적이 체적의 95%이상이 될 수 있도록, Dmax가 처방선량의 107%넘지 않게 치료계획하였다. 자세오차는 X축, Y축, Z축으로 ±1mm/±3mm/±5mm를 동일하게 적용하여 비교평가하였다. 결 과 : 자세오차 시 피부선량의 변동성은 처방선량 대비 약 106%에서 약 123%였으며 가장 큰 피부선량의 증가는 X축의 바깥쪽(lateral) 방향 5mm 자세오차에서 49.24 Gy였다. 처방선량 대비 107%이상의 영역은 skin lateral에서 6.87 cc로 가장 넓게 나타났다. 결 론 : 좌측 유방암 용적 변조 회전 방사선 치료 시 자세오차가 일어났을 경우 X축의 바깥쪽 방향에서 처방선량 대비 가장 큰 피부선량의 차이가 나타났다. 이를 통해 치료실 CBCT 정합 시 치료받는 쪽 유방의 Y축, Z축을 정합하는 것도 물론 중요하지만 X축을 정합하는데 더 노력한다면 치료 간 피부선량의 변동성을 더 줄이기 위한 효과적인 방법으로 사료된다.